Canada: Increases Patent Term for Eligible Pharmaceutical Patents

Qatar: Trademark Renewal Formalities Updated
September 19, 2017
European Trademark Law: Additional Changes Come Into Force on October 1, 2017
September 27, 2017
Show all

Canada: Increases Patent Term for Eligible Pharmaceutical Patents

A new statutory and regulatory framework came into effect in Canada on September 21, 2017 which will allow Canada to fulfill its obligations under the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union which would allow for the extension of the term for drug patents due to delays resulting from regulatory approval.  At present the United States, Japan and Australia currently have such adjustments to the terms of drug patents.  If eligible, the term of a patent can be extended by up to two years.

Source:  Kirby IP